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Prior to anaphase in Saccharomyces cerevisiae, Cdc14
protein phosphatase is sequestered within the nucleolus
and inhibited by Net1, a component of the RENT complex
in budding yeast. During anaphase the RENT complex
disassembles, allowing Cdc14 to migrate to the nucleus
and cytoplasm where it catalyzes exit from mitosis. The
mechanism of Cdc14 release appears to involve the polo-
like kinase Cdc5, which is capable of promoting the dis-
sociation of a recombinant Net1Cdc14 complex in vitro
by phosphorylation of Net1. We report here the phospho-
rylation site mapping of recombinant Net1 (Net1N) and a
mutant Net1N allele (Net1N-19m) with 19 serines or
threonines mutated to alanine. A variety of chromato-
graphic and mass spectrometric-based strategies were
used, including immobilized metal-affinity chromatogra-
phy, alkaline phosphatase treatment, matrix-assisted la-
ser-desorption post-source decay, and a multidimen-
sional electrospray mass spectrometry-based approach.
No one approach was able to identify all phosphopeptides
in the tryptic digests of these proteins. Most notably, the
presence of a basic residue near the phosphorylated res-
idue significantly hampered the ability of alkaline phos-
phatase to hydrolyze the phosphate moiety. A major goal
of research in proteomics is to identify all proteins and
their interactions and post-translational modification
states. The failure of any single method to identify all sites
in highly phosphorylated Net1N, however, raises signifi-
cant concerns about how feasible it is to map phospho-
rylation sites throughout the proteome using existing
technologies. Molecular & Cellular Proteomics 1:
186–196, 2002.
Protein phosphorylation is arguably the most important re-
versible post-translational modification that occurs in cells.
Protein kinases and phosphatases add or remove, respec-
tively, phosphate groups that regulate enzymatic activity, pro-
tein-protein interactions, and protein tertiary structures.
Knowledge of the sites of phosphorylation on a particular
protein can aid in understanding the mechanism by which that
protein affects a biological pathway.
A variety of techniques are available for detecting phospho-
rylated peptides. Traditional methods such as TLC and Ed-
man sequencing have the disadvantages that they typically
require the use of radioactively labeled sample and either prior
knowledge of the protein sequence or the ability to make
some assumptions about the peptide sequence. Proteins can
be labeled in vivo using [32P]orthophosphate or in vitro using
purified kinase and [-32P]ATP. The phosphorylated proteins
are enzymatically digested, and the phosphopeptides are iso-
lated by high performance liquid chromatography (HPLC)1 or
two-dimensional TLC and detected by scintillation counting or
autoradiography. The HPLC fraction or excised TLC spot is
subjected to phosphoamino acid analysis and manual Edman
sequencing, monitoring for a loss of radioactivity at each
cycle. Because there is typically not an adequate amount of
peptide present to detect the non-labeled amino acids, the
phosphorylation site must be deduced by comparing the cy-
cle number at which the radioactivity is released with a list of
predicted peptides to identify those that contain serine, thre-
onine, or tyrosine at the same position.
Alternative methods for detecting phosphopeptides utilize
mass spectrometry (MS) and abrogate the need for radioac-
tivity. MS-based techniques include matrix-assisted laser de-
sorption/ionization (MALDI) to detect peptides that can lose
phosphate under conditions of post-source decay (PSD),
MALDI analysis of peptides before and after treatment with
alkaline phosphatase, and electrospray-based MS methods
that detect phosphate-specific marker ions.
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Under the appropriate conditions phosphopeptides can un-
dergo collision-induced dissociation (CID) to produce ions
that are phosphate-specific (1). CID of serine-, threonine-, and
tyrosine-phosphorylated peptides under negative ion condi-
tions results in the formation of phosphopeptide-specific
marker ions at m/z 79 (PO3
) and m/z 63 (PO2
). Under
positive ion conditions serine- and threonine-phosphorylated
peptides undergo loss of 98 Da (H3PO4
) and 80 Da (HPO3
)
from the molecular ion, whereas tyrosine-phosphorylated
peptides preferentially lose 80 Da. These characteristic frag-
mentations in the positive and negative ion modes are signa-
tures for phosphopeptides.
Detection of phosphopeptides by MALDI-PSD takes ad-
vantage of the phosphorylation-specific losses from the mo-
lecular ion (1). MALDI-PSD is performed on reflectron-
equipped MALDI-TOF instruments. The molecular ion of
interest is selected using an ion gate and undergoes post-
source decay in the first field-free region of the instrument.
The reflectron then energy-focuses the fragments such that
they are detected at the correct mass. Observation of the loss
of 80 or 98 Da from the molecular ion is diagnostic for phos-
phorylated peptides.
Another phosphopeptide detection method for which
MALDI-TOF is a convenient readout is the treatment of pep-
tides with alkaline phosphatase (2, 3). This results in an 80-Da
shift to lower mass for the previously phosphorylated peptide.
Thus, by comparing MALDI spectra recorded before and after
alkaline phosphatase treatment, and looking for peaks that
disappear from the treated sample, as well as peaks that
appear or increase in intensity, it is possible to identify can-
didate phosphopeptides.
Alkaline phosphatase treatment and PSD are both quick
and easy methods for detecting phosphopeptides; however,
unfractionated protein digests can be difficult to analyze by
these techniques because of their complexity. Furthermore, in
cases where the stoichiometry of phosphorylation is very low,
the phosphorylated form of the peptide may not be detected
in the initial MALDI spectrum. One way to circumvent this
problem is to selectively enrich a digest for phosphopeptides
using immobilized metal affinity chromatography (IMAC) (4–
6). IMAC uses resins that chelate metals such as gallium and
iron. When a peptide mixture is passed over an IMAC column
negatively charged phosphate groups bind the chelated metal
and are retained on the column. Unfortunately, the IMAC
interaction is not specific for phosphorylated peptides but is
due rather to the acidic nature of the phosphate group. Thus
non-phosphorylated peptides containing several acidic amino
acids can also bind to the column. Although enriching for
phosphopeptides, it is not uncommon for the IMAC eluate to
contain a mixture of phosphorylated and non-phosphorylated
peptides. To determine which of the peptides in the simplified
mixture are phosphorylated, the eluate can be analyzed by
MALDI-PSD or alkaline phosphatase treatment.
We have recently reported a multidimensional electrospray
MS-based approach to phosphopeptide mapping (7). This
technique takes advantage of the formation of phosphospe-
cific marker ions (m/z 63 and 79) that occur under CID con-
ditions in the negative ion mode. In the first dimension of the
analysis, the tryptic digest of a phosphoprotein is separated
by reverse-phase chromatography with a small portion of the
eluate being directed to a quadrupole mass spectrometer
whereas the remainder of the sample goes to a fraction col-
lector. Marker ions are produced by CID in the source and
detected in a selected-ion monitoring mode. An ion chromat-
ogram for m/z 63 and 79 is generated and synchronized with
the fraction collector to determine which fraction(s) contain
phosphopeptides.
Because most fractions will contain a mixture of phospho-
rylated and non-phosphorylated peptides, with the former
often at low stoichiometry, it is usually not sufficient to simply
know which fractions contain phosphopeptides. For this rea-
son, a portion of each phosphopeptide-containing fraction is
made basic and analyzed in the second dimension by nano-
electrospray MS using precursor ion scanning for m/z 79. This
experiment specifically detects only the phosphopeptides
present in each fraction and reports the m/z values that gave
rise to the phosphopeptide marker ion. At this point the phos-
phopeptides in each fraction are sequenced by MS/MS to
confirm their identity and determine the exact site(s) of
phosphorylation.
To evaluate the capability of our phospho-site mapping
strategy, we sought to apply it to the mapping of phospho-
rylation sites in the mitotic regulatory protein Net1. Net1 is a
component of the multifunctional RENT (regulator of the nu-
cleolus and telophase) complex in budding yeast. Prior to exit
from mitosis, Net1 sequesters the Cdc14 protein phospha-
tase subunit of RENT within the nucleolus and inhibits its
activity (8–11). During anaphase, Cdc14 is released from Net1
into the nucleus and cytoplasm where it catalyzes exit from
mitosis. The mechanism of this release event is not under-
stood but appears to involve the polo-like protein kinase
Cdc5.2 Interestingly, purified Cdc5 promotes the disassembly
of recombinant Net1Cdc14 protein complexes in vitro via
phosphorylation of Net1. To evaluate the physiological signif-
icance of this reaction, we sought to map sites in Net1N that
are phosphorylated by Cdc5. Although this approach seemed
simple in principle, it proved to be difficult, because Cdc5
phosphorylated many residues in Net1N. Here, we report the
multipronged strategy that we employed to comprehensively
identify phosphorylation sites even in the very heavily phos-
phorylated Net1N protein.
2 W. Shou, R. Azzam, S. L. Chen, M. J. Huddleston, C. Baskerville,
H. Charbonneau, R. S. Annan, S. A. Carr, and R. J. Deshaies, manu-
script in preparation.
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EXPERIMENTAL PROCEDURES
Net1N Expression and Phosphorylation
The Net1N protein, fused to a tag consisting of six histidine resi-
dues and a T7 tag (His6-T7-Net1N), was expressed in Escherichia coli
BL21(DE3) pLysS cells and purified on nickel nitrilotriacetic acid-
agarose beads (Qiagen) as described previously for p28Kix1 (12). To
prepare Net1N phosphorylated by moderate levels of Cdc5 (such that
50% release of Cdc14 from Net1N was obtained), we prepared four
tubes, each containing 100 l of anti-T7 beads (Novagen), 60 l of
His6-T7-Net1N (0.3–0.4 mg/ml), and 100 l of HEBD (20 mM Hepes,
pH 7.2, 150 mM NaCl, 2 mM EDTA, 0.1 mg/ml BSA, 1 mM DTT). The
mixture was rotated for 1 h at 4 °C, and beads were washed five times
with wash buffer (HBS (20 mM Hepes, pH 7.2, 150 mM NaCl)  0.2%
octylglucoside  1 mM DTT) and twice with kinase buffer (5 mM
TrisHCl, pH 8.0, 25 mM NaCl, 10 mM MgCl2, 1 mM DTT, 0.1 mg/ml
BSA, 1 mM ATP, 10 g/ml pepstatin  10 g/ml chymostatin  10
g/ml leupeptin). For the kinase reaction, the beads were supple-
mented with 100 l of 2 kinase buffer  95 l of H2O  2.0 l of
Cdc5 (0.5 mg/ml) and incubated at room temperature for 1 h. The
beads were subsequently washed six times with wash buffer and
three times with H2O and eluted three times with 100 l of 0.1%
trifluoroacetic acid. The eluates were pooled and dried under vacuum.
Pellets were dissolved in a total of 10 l of 8 M urea, which was then
supplemented with 30 l of 30 mM TrisHCl, pH 8.8. 1 l was loaded
on a 10% SDS-polyacrylamide gel and visualized using Coomassie
Blue staining.
Evaluation of Net1N Phosphosite Mutants
in Cdc14 Release Assay
Cdc5 phosphorylation sites were identified in this sample (see
below), and accordingly, His6-T7-Net1N-19m (Ser48, Ser56, Ser60,
Thr62, Ser64, Ser152, Ser156, Ser178, Ser179, Ser180, Thr192, Ser202,
Ser207, Ser242, Ser269, Ser270, Ser280, Thr288, and Ser335 all changed to
Ala) was constructed from a T7 promoter-driven His6-T7-Net1N Blue-
script plasmid using site-directed mutagenesis (Stratagene).
Different alleles of Net1N were transcribed from the Bluescript T7
promoter and translated in the presence of [35S]methionine using
rabbit reticulocyte lysate (TNT quick coupled transcription/translation
systems; Promega). For each Net1N mutant, 35 l of reticulocyte
lysate were incubated with 130 l of HEBD and 60 l of GST-Cdc14
beads for 1 h at 4 °C. To assemble GST-Cdc14 beads at 4 °C, 60 l
of protein A beads (Sigma) were incubated with 4 l of anti-GST and
100 l of HEBD for 1 h, washed four times with HBS  1 mM DTT,
incubated with 15 l of GST-Cdc14 (0.2 mg/ml)  150 l of HEBD for
1 h, and washed six times with HBS  1 mM DTT. GST-Cdc14 beads
that had captured [35S]-labeled Net1N were washed eight times with
HBS  0.2% Triton  1 mM DTT and twice with kinase buffer, equally
distributed into four tubes, and exposed to different amounts of
kinase in a 30-l reaction at 22 °C for 35 min. After the kinase
reaction, the supernatant was transferred to new tubes. The beads
were washed once with 70 l of HEBD, and the wash was pooled with
the supernatant and precipitated with trichloroacetic acid (10% final)
on ice for 30 min. After centrifugation in a microfuge for 10 min, the
pellet was saved as ”sup.“ Proteins present on the beads or in the sup
were analyzed by autoradiography.
Isolation of Phosphorylated Net1N-19m
His6-T7-Net1N-19m was purified by release from GST-Cdc14
beads upon treatment with Cdc5. 50 l of GST-Cdc14 beads (1
g/l) were incubated with 110 l of Net1N-19m (0.8 g/l) and 110
l of HEBD for 2 h at 4 °C and washed seven times with wash buffer
and once with kinase buffer. Beads from four such tubes were pooled
and split into ten tubes of 20-l beads. Each of these ten tubes was
supplemented with 80 l of 2 kinase buffer, 74 l of water, and 6 l
Cdc5 and incubated at room temperature for 4 h. Supernatant from
every two tubes was pooled, incubated with 100 l of anti-T7 beads
for 2 h at 4 °C, washed seven times with wash buffer and three times
with H2O, and eluted three times with 100 l of 0.1% trifluoroacetic
acid. The eluates were pooled and dried under vacuum. The pellets
were dissolved in a total of 7 l of 8 M urea and later supplemented
with 21 l of 30 mM TrisHCl, pH 8.8. 0.8 l of the final product was
loaded on a 10% SDS-polyacrylamide gel and visualized by Coomas-
sie Blue dye.
Digestion, Ga3-IMAC Enrichment, and Mass Spectrometric
Analysis of Phosphorylated Net1N Species
Purified recombinant Net1N in 1 M urea, 15 mM TrisHCl, pH 8.8,
and 50 mM ammonium bicarbonate was reduced with 2 mM DTT and
alkylated in 20 mM iodoacetamide prior to digestion with trypsin
(Promega) at a ratio of 1:20 (w/w). The digest was desalted using a gel
loader pipette tip microcolumn (13) packed with POROS R2 (PerSep-
tive Bioscience). Peptides in the flow-through were captured on a
Hypercarb Graphitic Carbon (Hypersil) microcolumn. The microcol-
umn, packed with 250 g of Hypercarb was equilibrated and washed
with 0.1% formic acid, and peptides were eluted with 2 l of 60%
acetonitrile, 0.1% formic acid.
Ga3-IMAC Enrichment—Phosphopeptide enrichment of the mix-
ture eluting from the POROS R2 column was accomplished using
Ga3-IMAC, based on the procedure of Posewitz and Tempst (6). The
peptide mixture that was eluted from the POROS R2 microcolumn
was applied directly to the Ga3-IMAC microcolumn, which was
packed with 2 mg of POROS MC (PerSeptive Biosystems) charged
with 80 l of 100 mM GaCl3 and equilibrated with 0.1% trace metal
grade acetic acid. The IMAC column was washed with 30 l of 0.1%
acetic acid, 30 l of 30% acetonitrile, and 30 l of 0.1% acetic acid.
Peptides were eluted in 15 l of 200 mM NaPO4, pH 8.4, directly onto
a second POROS R2 microcolumn for desalting. The POROS R2
microcolumn was equilibrated and washed with 0.1% formic acid,
and peptides were eluted with 2 l of 60% acetonitrile, 0.1% formic
acid.
Alkaline Phosphatase Treatment—Alkaline phosphatase reactions
were done directly on the MALDI target. An aliquot of each sample
(0.25 l) was mixed with an equal volume of alkaline phosphatase
(calf intestine; Roche Molecular Biochemicals) that had been diluted
1:10 in 100 mM ammonium bicarbonate. The reactions were incu-
bated for 5 min at room temperature followed by addition of 0.5 l of
-cyano-4-cinnamic acid matrix (10 mg/ml in 50% acetonitrile, 50%
ethanol).
LC-ESMS of Intact Net1N—Intact Net1N protein (100 pmol) was
acidified with 0.1% trifluoroacetic acid prior to injection on a 0.5 
150-mm Magic C18 column. Protein was eluted with a gradient of
5–60% acetonitrile, and the eluent was split 1:20 before being intro-
duced into the Micromass Q-tof mass spectrometer. The molecular
mass of the intact protein was recorded in the positive ion mode. Data
were summed and deconvoluted using the Micromass Masslynx with
MaxEnt 1 software.
MALDI and MALDI-PSD—Samples for MALDI and MALDI-PSD
were mixed 1:1 with -cyano-4-cinnamic acid matrix (10 mg/ml in
50% acetonitrile, 50% ethanol), and 0.5 l was spotted on the target.
Spectra were acquired in reflectron mode on a Micromass TofSpec
SE. Spectra were calibrated externally using two peptide standards.
PSD spectra were acquired as single segments. Precursor ions were
isolated using a single Bradbury-Neilson ion gate.
MS/MS Sequencing of Phosphopeptides—To sequence the phos-
phopeptides, approximately one-half of the sample was dried, recon-
stituted in 2 l of 50% methanol, 5% formic acid, and transferred to
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a nanospray needle (Protana). Nanospray MS/MS mass spectra were
collected on a Micromass Q-tof hybrid quadrupole time-of-flight
mass spectrometer equipped with a Z-spray source. Data were ana-
lyzed using the Masslynx data system.
Digestion and Mass Spectrometric Analysis of
Phosphorylated Net1N-19m
Phosphorylation site mapping of the Net1N-19m mutant was done
using a multidimensional ESMS-based strategy that has been de-
scribed previously (7). HPLC was carried out on a Hitachi L6200A
system. The flow from the HPLC pumps was split pre-column from
400 l/min to 4 l/min using an LC Packings Accurate microflow
splitter. Mobile phases were 2% acetonitrile, 0.02% trifluoroacetic
acid (Solvent A) and 90% acetonitrile, 0.02% trifluoroacetic acid
(Solvent B). Samples were acidified with 0.1% trifluoroacetic acid and
then injected onto a 300-m  5-mm PepMap C18 (LC Packings)
cartridge that had been installed in place of the sample loop on the
injector (Rheodyne model 8125). The cartridge was washed with
0.1% trifluoroacetic acid, the injector was rotated into the inject
position, and the sample was back-eluted off the trap onto a 180-
m  150-mm PepMap analytical column (LC Packings) using a
gradient of 5–50% Solvent B in 20 min and then 50–95% Solvent B
in 5 min. The flow was split post-column by a 150-m microvolume
Valco tee inserted into a Micromass nanoflow ion source such that 0.6
l/min flowed to a 20-m inner diameter tapered fused silica electro-
spray tip (New Objectives) and the remainder to a prep line for manual
collection of fractions. Electrospray mass spectra were recorded in
the negative ion mode on a PE Sciex API-III atmospheric pressure
ionization triple quadrupole tandem mass spectrometer equipped
with a high pressure collision cell (PE Sciex). Phosphospecific marker
ions were generated in the source vacuum prior to the Q1 mass filter
by the application of a high orifice voltage.
Fractions that were identified in the phosphospecific LC-ESMS
scan to contain phosphopeptides were then analyzed by precursor
scan to determine the m/z of the phosphopeptides (7). One-fourth to
one-half of the fraction was dried, reconstituted in 2 l of 50%
methanol, 10% concentrated ammonium hydroxide, and transferred
to a nanoelectrospray needle (Protana). A full scan negative ion spec-
trum was recorded, followed by a negative ion precursor scan for m/z
79 on a PE Sciex API-III triple quadrupole mass spectrometer. Pep-
tides were sequenced using a Micromass Q-tof mass spectrometer
equipped with a nanoES source as described above.
RESULTS
Analysis of Net1N Phosphorylation—Net1 accumulates in a
hyperphosphorylated form in cdc14ts cells arrested in late
anaphase at the non-permissive temperature (8). In an earlier
study, we found that the Polo-like kinase Cdc5 is necessary to
disrupt the RENT complex and to free nucleolar Cdc14 in late
mitosis, that elevated Cdc5 activity provokes ectopic mobili-
zation of Cdc14 in pre-anaphase cells, and that the phospho-
rylation state of Net1 is regulated by Cdc5 during anaphase.2
These observations prompted us to examine whether Cdc5-
mediated phosphorylation could directly destabilize the RENT
complex. Indeed, recombinant Cdc5 kinase can disassemble
the RENT complex in vitro by phosphorylating Net1 and
thereby reducing its affinity for Cdc14.2 In addition, a trun-
cated form of Net1 containing amino acids 1–341 (Net1N)
expressed and purified from E. coli retains the ability to bind
and inhibit Cdc14 (10). We reasoned that if phosphorylation of
Net1 by Cdc5 was indeed responsible for disrupting the RENT
complex, then a mutant Net1 or Net1N lacking Cdc5 phos-
phorylation sites should bind Cdc14 even in the presence of
active Cdc5. We therefore sought to determine the sites of
phosphorylation of Net1N.
Net1N and Net1N-19m proteins were expressed as His6-T7
fusions in E. coli and phosphorylated in vitro with Cdc5 (Fig.
1). To determine the extent to which Cdc5 phosphorylated
Net1N in vitro, the molecular masses of the intact protein
before and after incubation with purified Cdc5 were deter-
mined by LC-ESMS (Fig. 2). The mass of the non-phospho-
rylated protein was determined to be 40,393 Da, consistent
with the average mass calculated for the des-Met1 form of
Net1N (40392 Da). After incubation with Cdc5, a heterogene-
ous distribution of protein molecular masses, each differing
by 80 Da, was observed. The range of the mass distribution
suggests that each mole of Net1N was modified with 3 to 12
mol of phosphate. However the presence of additional phos-
phate groups at low stoichiometry could not be ruled out as
the spectrum is rather noisy. Mass spectra of multiply phos-
phorylated proteins are inherently noisy relative to the un-
phosphorylated protein as the signal is being distributed
across multiple forms.
Phosphorylated Net1N was digested with trypsin, and a
small aliquot was treated with alkaline phosphatase. MALDI
spectra were obtained for the phosphatase-treated and un-
treated samples and compared. In the treated sample, disap-
pearance of peaks present in the untreated sample and con-
comitant appearance of new peaks or increases in the
intensity of peaks at a mass 80 Da lower represent the cleav-
age of phosphate from a phosphopeptide to create a non-
phosphorylated peptide. Fig. 3 shows that five phosphoryl-
ated peptides could be identified in this way from the
FIG. 1. Cdc5-phosphorylated His6-T7-Net1N protein samples
for mass spectrometry analysis. Net1N phosphorylated by moder-
ate amounts of Cdc5 (A) and Net1N-19m released from GST-Cdc14
beads by Cdc5 (B) were loaded, together with molecular weight
markers and BSA, on a 10% SDS-polyacrylamide gel and visualized
by staining with Coomassie Blue. A fragment (Frag.) of Net1N (which
reacts to anti-T7 antibodies) was present in both samples.
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unfractionated tryptic digest of Net1N. This number is far
fewer than the minimum of 12 suggested by the molecular
mass distribution of phosphorylated Net1N.
Because the ionization of phosphopeptides might be sup-
pressed by the presence of large amounts of non-phospho-
rylated peptides in the unfractionated mixture, we sought to
enrich the sample for phosphopeptides using IMAC. The
MALDI spectrum of the peptides eluted from the IMAC col-
umn is shown in Fig. 4A. A number of the peaks in the MALDI
spectrum had broad, poorly resolved “satellite peaks” 90 Da
lower in mass. These satellite peaks are formed by metastable
decomposition in the field-free region after the ion source. Met-
astable ions do not possess the full accelerating potential and
do not penetrate the ion mirror fully. As a result, they appear at
the reflecting detector as broadened peaks of higher apparent
mass than expected. In this case, decomposition products re-
sulting from loss of H3PO4 appear 90 Da lower in mass from the
precursor instead of 98 Da lower. We verified that these were
metastable decompositions from phosphopeptides by perform-
ing PSD on each apparent precursor and observing the loss of
H3PO4 at the proper mass in the PSD spectrum (data not
shown). In this way we identified 10 phosphopeptides.
To identify phosphopeptides that did not show an observ-
able metastable product, we treated an aliquot of the IMAC
fraction with alkaline phosphatase and compared the MALDI
spectra taken before and after treatment (Fig. 4, A and B,
respectively). The spectrum of the treated sample was greatly
simplified relative to the untreated sample because of the
elimination of the metastable peaks and the collapse of mul-
tiply phosphorylated peptides into a single non-phosphoryl-
ated peak. Two peptides that had been identified by PSD as
being monophosphorylated were at least partially resistant to
treatment with alkaline phosphatase (peptides 10 and 14),
thus generating a false negative response. Both of these
peptides contained a basic residue adjacent to the phospho-
rylated amino acid. Peptide 10 was also found as the diphos-
phorylated form (Fig. 4, peptide 11). The second phosphoryl-
ation site on this peptide is five residues away from the
nearest basic amino acid, suggesting that it should be sus-
ceptible to phosphatase treatment. When the sample was
treated with alkaline phosphatase the peak for the diphospho-
rylated peptide disappeared leaving only a monophospho-
FIG. 2. Deconvoluted LC-ESMS spectra of Net1N prior (A) and
subsequent (B) to phosphorylation by Cdc5 protein kinase. 100
pmol of sample were injected onto a 0.5-mm inner diameter PepMap
C18 reverse-phase HPLC column. The protein was eluted with a
gradient of water:acetonitrile:trifluoroacetic acid with 1:20 of the elu-
ate being split to the mass spectrometer and the remaining sample
going to a transfer line for fraction collection.
FIG. 3. MALDI spectrum of the un-
fractionated Net1N tryptic digest
without (A) and with (B) treatment with
alkaline phosphatase. Peaks marked *
indicate those that disappeared upon
treatment with alkaline phosphatase
with a concurrent appearance of a peak
80 Da lower (Œ) in the alkaline phos-
phatase-treated sample. Only five phos-
phopeptides were detected in this man-
ner. Peaks are numbered corresponding
to the numbering in Table I. Many peaks
in the untreated sample were sodium ad-
ducts of peptides that disappeared or
were reduced in intensity upon treat-
ment with alkaline phosphatase, but
these peaks did not have a concurrent
appearance of a peak 80 Da lower in
mass. Peptide 10 only undergoes partial
dephosphorylation (see text for details).
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rylated peptide and no dephosphorylated peptide. In effect,
peptide 11 was converted to peptide 10. It is reasonable to
suggest that only the site away from the arginine residue is
being dephosphorylated. Fig. 3 also suggests that the mono-
phosphorylated peptide 10 is partially resistant to alkaline
phosphatase treatment, because it did not become fully de-
phosphorylated upon treatment with alkaline phosphatase.
We have also observed alkaline phosphatase resistance in a
synthetic peptide, KRPpSQRHGSKY-NH2, which contains an
arginine close to the phosphoserine (data not shown). In all we
identified eight phosphopeptides from the alkaline phospha-
tase treatment experiment, but no new phosphorylated se-
quences were discovered.
Experiments in our laboratory with small hydrophilic phos-
phopeptides have shown that these peptides are not always
captured efficiently by POROS R2 (data not shown). Because
the IMAC enrichment uses a POROS R2 desalting column
before affinity purification, we were concerned about the loss
of phosphopeptides from the Net1N tryptic digest. To capture
small or hydrophilic phosphopeptides that might flow through
the POROS R2 microcolumn, we applied the flow-through to
a porous graphitic carbon (Hypercarb) microcolumn. Hyper-
carb is a material that has been shown to bind some hydro-
philic substances better than C18-like resins. Fig. 5 shows the
MALDI spectrum of peptides that flowed through the R2 resin,
but were captured on Hypercarb, before (Fig. 5A) and after
(Fig. 5B) treatment with alkaline phosphatase. From this we
were able to identify four phosphopeptides that were not
FIG. 5. MALDI spectrum of peptides
eluted from the Hypercarb microcol-
umn. The flow-through from the POROS
R2 microcolumn was desalted on the
Hypercarb microcolumn to determine
whether there were peptides that were
unable to bind to POROS R2 but would
bind to Hypercarb. A, spectrum prior to
alkaline phosphatase treatment. Stars
indicate potential phosphopeptide
peaks that disappeared or were dimin-
ished in intensity after alkaline phospha-
tase treatment. B, spectrum after alka-
line phosphatase treatment. Œ indicates
peaks that appear or increase in inten-
sity after alkaline phosphatase treat-
ment. A total of 10 phosphopeptides
were detected in this sample, four of
which were absent from POROS R2-pu-
rified material. Peaks are numbered cor-
responding to the numbering in Table I.
FIG. 4. MALDI spectrum of Net1N
peptides captured by the Ga3-IMAC
column before (A) and after (B) treat-
ment with alkaline phosphatase. A,
peaks that disappear or are greatly di-
minished after alkaline phosphatase
treatment are marked with stars. Meta-
stable peaks, denoted by f, are formed
by the loss of HPO3
2 from phos-
phopeptides in the first field-free region
of the flight tube. B, The peaks marked Œ
are those that appeared or increased in
intensity after alkaline phosphatase
treatment. The diphosphorylated pep-
tide 11 is converted to the monophos-
phorylated peptide 10, which is resistant
to treatment to alkaline phosphatase
(see text for details). Peaks are num-
bered corresponding to the numbering
in Table I.
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present in the R2/IMAC fraction.
The overall coverage of tryptic peptides from the Net1N
sequence was analyzed by peptide mass mapping, compar-
ing peaks in the MALDI spectrum of the unfractionated tryptic
digest to the theoretical tryptic map of Net1N. To fill in several
sequence gaps in the MALDI data, we analyzed an additional
aliquot of the Net1N tryptic digest by positive ion LC-ESMS
and searched the data for the masses of missing peptides (
phosphate; data not shown). In this way we identified two
additional potential phosphopeptides as members of an
80-Da difference pair. We were able to partially sequence one
of these peptides (LNNGSPQSVQPQQIPSSSGVLR  1P;
amino acids 162–184; molecular mass 2500.2 Da) by MS/MS,
though the site of phosphorylation was not definitively assigned.
We were unable to sequence the remaining peptide, but its
mass matched that of the sequence LQVVLVPPSLQATMPIGF-
GYGPTIAESSQLLPNR  1P (amino acids 4–37; molecular
mass 3744.0 Da). The overall sequence coverage based on the
combined MALDI and LC-ESMS data was 98%.
Putative phosphopeptides identified by the presence of a
metastable peak, by alkaline-phosphatase treatment, by PSD
(data not shown), or from the positive ion LC-ESMS data were
sequenced by MS/MS to confirm the identity of the phos-
phopeptide and determine the site(s) of phosphorylation. In
total, we sequenced 15 of 16 possible phosphopeptides
(Table I). For those 15 phosphopeptides, 12 specific sites of
phosphorylation were determined. In only three cases (pep-
tides 160–184, 162–184, and 189–201) were we unable to
specify the exact location of the phosphate group. In these
three cases, the fragmentation data were not sufficient to
determine whether there was one specific site of phosphoryl-
ation or a mixed population of singly phosphorylated pep-
tides, modified at different sites.
Analysis of Net1N Mutants—Based on the mapped sites
(Table I), as well as other potential sites, a series of Ser/Thr3
Ala mutants were constructed (Table II). If Cdc5 phosphoryl-
ation on any of these sites was critical in disrupting the
binding of Cdc14 to Net1, then the non-phosphorylatable
Net1 mutants should form a complex with Cdc14 that is
resistant to disruption by Cdc5. To test this hypothesis, ra-
diolabeled mutant and wild-type Net1N proteins bound to
GST-Cdc14 beads were treated with increasing amounts of
Plx1, a Polo-like kinase from Xenopus that is closely related to
Cdc5. Because Plx1 (Polo-like kinase in Xenopus; see Ref. 14)
can disrupt the RENT complex in vitro (data not shown) and is
expressed at high levels in insect cells, we used Plx1 instead
of Cdc5 in these tests. We verified independently that Net1N
phenotypes were equivalent in assays using Plx1 or Cdc5
(data not shown). The amount of Net1N released into the
supernatant or that remained bound to GST-Cdc14 beads
was analyzed using autoradiography.
As an example, 0.3 l of Plx1 released 90% of wild-type
Net1N from GST-Cdc14 beads, whereas 1 l of Plx1 had to
be used to release 80% of Net1N (Ser48 Ser60 Ser64 Ser242
Ser3353 Ala) (Fig. 6A). Thus, this mutant allele of Net1N was
3-fold more resistant to Plx1 than wild-type Net1N. A list of
mutants and their phenotypes are listed in the top portion of
Table II.
Despite the large number of phosphorylated sites that had
been mutated, Net1N-19m could still be phosphorylated by
Cdc5 and was still capable of dissociating from Cdc14 in the
in vitro assay when the level of Plx1/Cdc5 was elevated 3-fold
(data not shown). One possibility was that one or more critical
Cdc5 phosphorylation sites were overlooked using the com-
bined MALDI-IMAC mapping strategy or that Cdc5 phospho-
rylated secondary sites on Net1N once the primary sites were
eliminated. To address these possibilities, Net1N-19m protein
released from GST-Cdc14 beads by Cdc5 was subjected to
phosphorylation site mapping for the following two reasons:
1) Net1N-19m contains many fewer phosphorylation sites
TABLE I
Phosphopeptides isolated from Net1N phosphorylated in vitro by Cdc5
Phosphorylated amino acids that were definitively identified are in bold. Residues that could potentially be phosphorylated are in italics.
Peptide Sequence Amino acids Mr
1 TNMAQSAGDApSLQYANLR 38–55 1989.9
2 SANVpSFTPSYFNQSR 56–70 1783.8
3 SANVpSFTPSYFNQSR  2P 56–70 1863.8
4 pSANVpSFTPpSYFNQSR 56–70 1943.8
5 VILKNEIDLDDSAPVpSLYK 137–155 2211.1
6 SKLNNGSPQSVQPQQQIPSSSGVLR  1P 160–184 2715.4
7 LNNGSPQSVQPQQQIPSSSGVLR  1P 162–184 2500.2
8 KRPPpTGTTTTTTIR 188–201 1609.9
9 RPPTGTTTTTTIR  1P 189–201 1481.8
10 IVSNNSDDEDEDIGERpSFLPPPTQPQSPPIR 226–256 3528.6
11 IVSNNpSDDEDEDIGERpSFLPPPTQPQSPPIR 226–256 3608.6
12 ISpSGIDAGKK 257–266 1054.5
13 IKpSSIVEEDIVSR 267–279 1553.8
14 SSIVEEDIVSRpSATVDPDKpTKQQR 269–292 2847.4
15 SATVDPDKpTKQQR 280–292 1552.8
Phosphorylation Site Mapping of Hyperphosphorylated Proteins
192 Molecular & Cellular Proteomics 1.3
than Net1N, which simplifies the task of mapping; and 2) key
phosphorylation site(s) on Net1N-19m that influence the in-
teraction between Net1 and Cdc14 should be phosphorylated
in all released protein molecules.
To improve our confidence in the phosphopeptide mapping
results we used an ESMS-based multidimensional mapping
strategy developed in our laboratory over the past few years
and proven to be highly reliable for all phosphorylation map-
ping problems. The phosphopeptide-specific LC-ESMS ion
trace for a tryptic digest of Net1N-19m phosphorylated by
Cdc5 shows a highly complex profile (Fig. 7A), indicating that
despite the large number of mutations Net1N-19m was still
extensively phosphorylated by Cdc5. All of the HPLC frac-
tions shown to contain phosphopeptides by means of the
phosphopeptide-specific trace were analyzed by precursor
scans for m/z 79, to identify the phosphopeptides present in
each fraction. The precursor ion scan for one such fraction is
shown in Fig. 7C. This spectrum shows more than 20 peaks
corresponding to various charge states for two unique pep-
tide sequences phosphorylated to different extents. Compar-
ison of the precursor scan of this fraction (Fig. 7C) with the
positive ion spectrum for the same fraction (Fig. 7B) shows
that precursor-ion scanning for m/z 79 can detect phos-
phopeptides that are not readily observed in the full-scan
mass spectra. The latter contain many non-phosphorylated
peptides, some of which obscure the signals for the phos-
phorylated peptides. For example the highly phosphorylated
332–371 peptide would have gone undetected if not for the
selectivity of the precursor ion scan. To confirm the sequence
assignments and determine the exact site(s) of phosphoryla-
tion for phosphopeptides identified in the precursor ion scans,
FIG. 6. Mutant alleles of Net1N show a range of defects in the in
vitro release assay. [35S]-Labeled wild-type or mutant Net1N was
captured by GST-Cdc14 beads and treated with the indicated amounts
of Plx1. Net1N protein released into the supernatant (Sup.) or that
remained bead-bound (Bead) was analyzed by autoradiography.
TABLE II
Net1N mutants and their phenotypes
Mutant Net1N mutant allelesa -Fold defect
1 S60 S64 S242 S335 3
2 S60 S64 S242 S48 3
3 S60 S64 S242 S335 S48 (5m) 3
4 S60 S64 S242 S335 S48 S269 S270 3
5 S60 S64 S242 S335 S48 S269 S270 S207 3
6 S60 S64 S242 S335 S48 S269 S270 S207 S152 S56 3
7 S60 S64 S242 S335 S48 S152 S156 S280 3
8 S60 S64 S242 S335 S48 S269 S270 S207 S152 S56 S156 S280 3
9 S60 S64 S242 S335 S48 S269 S270 S207 S152 S56 S156 S280 S202 T62 S178 S179 S180 3
10 S60 S64 S242 S335 S48 S269 S270 S207 S152 S56 S156 S280 S202 T62 S178 S179 S180 T192 T288 (19m) 3
11 S60 S64 S242 S335 S48 S269 S270 S207 S152 S56 S156 S280 S202 T62 S178 S179 S180 T192 T288 S12
T16 T26 S30 S31
10
12 S60 S64 S242 S335 S48 S12 T16 T26 S30 S31 10
13 S60 S64 S242 S48 S12 T16 T26 S30 S31 10
14 S60 S64 S242 S335 S48 T26 3
15 S60 S64 S242 S335 S48 T26 S30 S31 10–30
16 S60 S64 S242 S335 S48 T26 S30 S31 T38 T282 10
17 S60 S64 S242 S335 S48 T26 S30 S31 S223 S224 S301 T302 10
18 S60 S64 S242 S335 S48 S269 S270 S207 S152 S56 S156 S280 S202 T62 S178 S179 S180 T192 T288 T16
T26 S30 S31 S223 S224 S228 S231 S301 T302
10b
19 S60 S64 S242 S335 S48 S30 S31 (7m) 30
20 S60 S64 S242 S335 S48 S30 S31 T16 S223 S224 S228 S231 S295 S301 T302 T194 T195 T196 T197 30
a All indicated amino acids were mutated to alanine.
b High background level of release when kinase was not included in the reaction, suggesting weakened interaction between the mutant
Net1N and Cdc14.
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each phosphopeptide was analyzed by MS/MS. The MS/MS
spectrum of the 4 charge state for the quadruply phospho-
rylated 4–55 peptide identified in the precursor ion scan of
fraction 6 (Fig. 7C) is shown in Fig. 7D. Because of the size of
the peptide (5863 Da), the spectrum is quite complex. Never-
theless, the high quality of the data, which has resolution
sufficient to determine the charge states for each fragment
ion, allowed us to assign three of the phosphate groups un-
equivocally, whereas the fourth could be narrowed down to one
of two adjacent serines. Altogether, we were able to sequence
16 of the 20 phosphopeptides identified from the precursor ion
scans. These sequences, along with the proposed sequences
for the other phosphopeptides, are listed in Table III.
Of the 16 phosphopeptides that were sequenced from the
mutant Net1N-19m, only six specific phosphorylation sites
could be identified definitively. On the other hand, an addi-
tional 20 sites were shown to be potentially phosphorylated.
This is in stark contrast to the phosphopeptides sequenced
from the wild-type Net1N, for which 12 sites were definitively
assigned in 15 phosphopeptides. The apparent heterogeneity
in the mutant suggests that many of these sites were nonspe-
cifically phosphorylated by Cdc5 in the absence of the pre-
ferred phosphorylation sites.
More Net1N mutants were constructed based on the new
mapping data, and their propensities to release Cdc14 in a
Cdc5-dependent manner are summarized in the lower half of
Table II. One of the most severe mutants (Ser60 Ser64 Ser242
Ser335 Ser48 Ser30 Ser313 A) displayed a 30-fold defect in the
release assay (the effect of 3 l of Plx1 on Net1N-7m is similar
to that of 0.1 l of Plx1 on wild-type Net1N; see Fig. 6B).
CONCLUSIONS
In its unphosphorylated state, a recombinant, truncated
form of Net1 (Net1N) from Saccharomyces cerevisiae binds to
FIG. 7. A, selected ion chromatogram of the reverse-phase LC separation of the tryptic digest of Net1N-19m. The digest (130 pmol) was
injected on a 180-m  15-cm PepMap C18 column flowing at 4 l/min. The flow was split such that 0.6 l of the sample went to the mass
spectrometer and the remainder to a prep line for manual fraction collection. The mass spectrometer was set to detect m/z 63 and 79,
diagnostic markers for phosphate loss. The chromatogram represents the sum of the signals for these two markers. B, positive ion spectrum
acquired. C, precursor scan of one fraction from the reverse-phase LC separation of the Net1N-19m tryptic digest. One-fourth to one-half of
the fraction was dried and reconstituted in 2 l of 50% methanol, 5% concentrated ammonium hydroxide. First a negative ion spectrum was
acquired and then the precursor scan for ions producing m/z 79 marker ions. Another portion of the fraction is dried down and brought up in
50% MeOH, 5% formic acid. D, a quadruply phosphorylated, 4 ion with m/z 1466 from this fraction was selected for tandem mass
spectrometry.
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immobilized recombinant Cdc14. Phosphorylation of Net1N
by the Cdc5 protein kinase results in the release of Net1N
from Cdc14. Cdc5 incorporates from 3–12 phosphates per
molecule of Net1N. What molecular mass analysis of the
intact phosphoprotein does not reveal, however, is whether all
Net1N molecules phosphorylated on a given number of sites,
e.g. 8, are all phosphorylated on the same octet of residues.
Thus, substantially more than 12 different residues on Net1N
may be phosphorylated by Cdc5. The sites of phosphoryla-
tion on Net1N were mapped using a variety of biochemical
and mass spectrometric techniques, including alkaline phos-
phatase treatment and immobilized metal affinity chromatog-
raphy, which revealed at least 12 phosphorylation sites on 15
phosphopeptides. Based on these sites of phosphorylation
and other criteria, a mutant was created in which 19 serines or
threonines were modified to alanine to test whether preclud-
ing phosphorylation of these sites by Cdc5 could prevent
release of Net1N from Cdc14. Despite the large number of
mutations created, the Net1N-19m mutant was still phospho-
rylated by Cdc5, and this phosphorylation resulted in the
dissociation of Net1N-19m from Cdc14.
To determine what Cdc5 phosphorylation sites persisted in
Net1N-19m, a phosphate-specific marker ion mass spectro-
metric strategy was used. A total of 20 phosphopeptides were
sequenced, but only six phosphorylation sites were defini-
tively assigned, with another 20 sites flagged as being poten-
tially phosphorylated. Importantly, a mutant of Net1N that
lacks a subset of sites identified in the first and second round
of phosphorylation site mapping shows a profound inability to
release tightly bound Cdc14 upon treatment with Cdc5 pro-
tein kinase. Remarkably, however, this mutant does not ex-
hibit any detectable defect in the release of Cdc14 from Net1
during the exit from mitosis in budding yeast. These results
establish two important points. First, even though it is tech-
nically feasible to identify those sites that mediate the phos-
phorylation-dependent release of Cdc14, identification of the
relevant sites required a multipronged strategy. MALDI-based
mapping of Net1N, even when coupled to different upstream
chromatographic separations (reverse-phase, Hypercarb,
IMAC) was unable to identify all of the sites whose phospho-
rylation by Cdc5 precludes association with Cdc14. This re-
sult has significant implications for proteomic strategies to
map phosphorylation sites in regulatory proteins on a global
scale. It is evident from our data that any strategy that is
based on a single chromatographic separation technique or
that employs only one form of ionization is unlikely to uncover
all of the phosphorylation sites in heavily phosphorylated pro-
teins. Given that some of the regulatory proteins that have
been characterized in most detail are phosphorylated either
on multiple sites (e.g. Rb, Cdc25) or by multiple distinct pro-
tein kinases (e.g. p53), the data that emerge from simplistic
schemes to map phosphorylation sites throughout the pro-
teome are likely to miss many of the critical phosphorylations
that regulate cellular biology. Rather, it appears that dedi-
cated analyses of individual proteins are likely to produce the
most reliable picture of the phosphorylation status of a protein
until major advances in technology enable determination of
phosphorylation sites in low abundance proteins on a global
scale.
A second significant conclusion that emerges from the work
described here and in Shou et al.2 concerns the importance of
making mutations in cis to confirm hypotheses about how a
TABLE III
Phosphopeptides isolated from Net1N-19m phosphorylated in vitro by Cdc5
Phosphorylated amino acids that were definitively identified are in bold. Residues that could potentially be phosphorylated are in italics.
Sequence Amino acids Mr
LQVVLVPPSLQATMPIQFGYGPTIAESSQLLPNRTNMAQSAGDAALQYANLR  2P 4–55 5699.9
LQVVLVPPSLQATMPIQFGYGPTIAESSQLLPNRTNMAQSAGDAALQYANLR  3P 4–55 5779.9
LQVVLVPPSLQATMPIQFGYGPpTIAESSQLLPNRpTNMAQpSAGDAALQYANLR  4P 4–55 5859.9
LQVVLVPPSLQATMPIQFGYGPTIAESSQLLPNRTNMAQSAGDAALQYANLR  5P 4–55 5939.9
KRPPAGTTTTTTIR  1P 188–201 1579.8
KRPPAGTTTTTTIR  2P 188–201 1659.8
VSTPLAR  1P 210–216 822.4
QIYPPPSSK  1P 217–225 1095.5
QIYPPPSSKIVSNNSDDEDEDIGER  1P 217–241 2883.3




LLSGTPIMSTMTPNR  1P 293–307 1697.8
LLSGTPIMSTMTPNR  2P 293–307 1777.8
VTLTGQR  1P 308–314 853.4
VVSEHAHKNELVFSASASSSAFANGGTGGSIDVEHHHHHH  1P 315–354 4262.9
VVSEHAHKNELVFSASASSSAFANGGTGGSIDVEHHHHHH  2P 315–354 4342.9
VVSEHAHKNELVFSASASSSAFANGGTGGSIDVEHHHHHH  3P 315–354 4422.9
VVSEHAHKNELVFSASASSSAFANGGTGGSIDVEHHHHHH  4P 315–354 4502.9
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particular phosphorylation event(s) regulates a biological
process. The evidence supporting the hypothesis that phos-
phorylation of Net1 by Cdc5 triggers release of Cdc14 is quite
strong. 1) Cdc14 is not released from Net1 in Cdc5 mutants,
2) Cdc14 is precociously released from Net1 in cells that
overproduce Cdc5, 3) Cdc5 controls the phosphorylation
state of Net1 in vivo, and 4) Cdc5 can disassemble RENT
complexes in vitro and is able to interfere directly with Cdc14-
Net1 interaction via phosphorylation of Net1.2 Nevertheless, a
mutant of Net1 that no longer releases Cdc14 upon treatment
with Cdc5 in vitro exhibits no defect in release of Cdc14
during progression through anaphase in vivo. Thus, although
Cdc5 is involved in the release of Cdc14 from Net1, our data
suggest that its involvement is indirect. Many studies have
implied a link between a biological response and phosphoryl-
ation of a specific protein based on correlative data or based
on data generated with overproduced proteins. Our observa-
tions underscore the importance of mapping phosphorylation
sites and making cis mutations to confirm the existence of
specific regulatory circuits.
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